Articles
9 de August de 2017
Overview of Medicinal product regulation and product liability in Brazil
The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.
The Q&A is part of the global guide to life sciences law. For a full list of jurisdictional Q&As visit www.practicallaw.com/lifesciences-guide.
Share:
Last related news
14 de September de 2026
Guidance Note: Brazil – Direct Marketing
Partner Claudio Barbosa and Attorney at Law Larissa Martins have recently authored the article “Data Guidance: Brazil – Direct Marketing” for the … Guidance Note: Brazil – Direct Marketing
8 de July de 2026
SEP Patents: Respect for the principle of objective good faith in negotiations, the duty of procedural loyalty, and the burden of proof regarding FRAND elements
ABSTRACT: The increasing judicialization of disputes involving Standard Essential Patents (SEPs) has shifted the focus of legal debate beyond the mere assessment … SEP Patents: Respect for the principle of objective good faith in negotiations, the duty of procedural loyalty, and the burden of proof regarding FRAND elements
28 de January de 2026
Data Protection Day: Between Regulatory Maturity and the New Challenges of Artificial Intelligence
Data Protection Day, celebrated on January 28, goes beyond symbolism. Each year, the date reinforces the consolidation of personal data protection, with … Data Protection Day: Between Regulatory Maturity and the New Challenges of Artificial Intelligence